Literature DB >> 12049962

Optimal pulse-inversion imaging for microsphere contrast agents.

Anil J Reddy1, Andrew J Szeri.   

Abstract

Microbubbles are used as contrast agents because they scatter incident ultrasound (US) efficiently. Pulse-inversion imaging makes use of the asymmetrical difference in response of a bubble to an US pulse and its symmetrical opposite to obtain improved contrast. In this theoretical work, the principle of pulse-inversion imaging is expanded upon by finding the optimal pulse shape to maximize the signal from a bubble. Given a limit on driving intensity, a suitable norm of the bubble response is maximized using optimal control theory to identify the proper pulse/antipulse driving protocol for a single bubble. The optimal pulse yields a several-fold increase in the normed response over the best sinusoidal pulse of the same driving intensity. It was found that the optimal driving for a single bubble also maximizes the nonlinear response of the cloud if its mean bubble size is the same as that of the single bubble.

Mesh:

Substances:

Year:  2002        PMID: 12049962     DOI: 10.1016/s0301-5629(02)00494-5

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  3 in total

1.  A new imaging strategy using wideband transient response of ultrasound contrast agents.

Authors:  Dustin E Kruse; Katherine W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2005-08       Impact factor: 2.725

2.  Optimization of Contrast-to-Tissue Ratio Through Pulse Windowing in Dual-Frequency "Acoustic Angiography" Imaging.

Authors:  Brooks D Lindsey; Sarah E Shelton; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2015-03-25       Impact factor: 2.998

3.  Optimization of contrast-to-tissue ratio by adaptation of transmitted ternary signal in ultrasound pulse inversion imaging.

Authors:  Sébastien Ménigot; Jean-Marc Girault
Journal:  Comput Math Methods Med       Date:  2013-03-20       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.